PH
Pharma Mar, S.A.
PHMMF · OTC
$94.60 +0.00% (+$0.00)
1M -2.83%
Market Cap 1.43B €
P/E Ratio 25.39x
Div. Yield 1.21%
ROE 23.66%
Bulios Fair Price
$52.16
44.9% downside
Current Price
$94.6
Undervalued Fair Value Overvalued
According to Bulios Fair Price, PHMMF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
35 /100
Fair P/FCF 27.92x
P/E 25.39x
P/B 5.69x
Growth
63 /100
Stable FCF growth 14.07%
EPS growth 16.89%
Book val. growth 4.13%
Profitability
89 /100
Strong Op. margin 15.23%
Gross margin 91.53%
FCF margin 23.38%
Quality
84 /100
Excellent ROA 14.28%
ROIC 14.90%
Asset turnover 0.56x
Debt
99 /100
Low Int. coverage 27.07x
Debt/Equity 0.18x
Net debt/EBITDA 0.61x
Stability
54 /100
Moderate EPS volatility 1,277.85%
Beta 0.67x
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PHMMF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jose Maria Fernandez Sousa-Faro
Employees
505
Headquarters
Madrid
Upcoming events
29 OCT
Earnings
Upcoming earnings report